Earnings in 2d
ENLV · NASDAQ · Biotechnology

Enlivex

Develops Allocetra for knee osteoarthritis and manages a RAIN-centered digital-asset treasury.

$1.36
After-hours close−0.01 (−0.47%)
At close$1.37(−7.12%)

Breakdown13F · Form 4

Institutions 1.44%242.6K sharesInsiders 3.02%509.1K sharesOther 95.54%16.08M shares

Shares outstanding 16.83M · Float 16.75M · 99.5% free float

Top shareholders13F · 13D/G · Form 4

HolderShares% outstandingFormFiled
Lind Global Asset Management XIV, LLC1.93M9.99%13GAug 13, 2026

Institutions13F, as of Mar 31, 2026

36 holders · 242.6K shares · 13 new positions · 21 increased · 6 reduced · 3 closed

HolderShares% outstandingChg q/qFiled
Diametric Capital, LP98.9K0.59%+98.9KnewMay 15, 2026
Ark Investment Management LLC41.9K0.25%+41.9KnewMay 12, 2026
Prelude Capital Management, LLC15.0K0.09%+15.0KnewMay 15, 2026
Two Sigma Investments, LP9.8K0.06%−3.2KMay 15, 2026
UBS Group AG9.2K0.05%+6.9KMay 5, 2026
Bank of America Corp /DE/8.7K0.05%+3.0KMay 18, 2026
Renaissance Technologies LLC8.5K0.05%−12.4KMay 14, 2026
JPMorgan Chase & Co8.4K0.05%+8.3KMay 13, 2026

Beneficial owners13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Lind Global Asset Management XIV, LLC9.99%1.93M13GAug 13, 2026
Steven Boydincl. Armistice Capital, LLC9.99%Nov 14, 2024
Armistice Capital, LLC7.53%13GMay 15, 2025

InsidersForm 4

InsiderRoleShares% outstandingFiled
Shai A. Novikdirector464.9K2.76%Mar 18, 2026
Avraham Havrondirector12.3K0.07%Mar 18, 2026
Oren Hershkovitzofficer: Chief Executive Officer11.5K0.07%Mar 18, 2026
Einat Galamidiofficer: Chief Medical Officer10.4K0.06%Mar 18, 2026
Shachar Shlosbergerofficer: Chief Financial Officer9.3K0.06%Mar 18, 2026
Gili Hartdirector5110.00%Mar 18, 2026
Roger Pomerantzdirector1650.00%Mar 18, 2026

Latest trades

Nothing filed in the last 12 months.

CongressHouse and Senate disclosures

Not reported.